Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Severe cutaneous adverse reactions to drugs: from patients to the national office for compensation of medical accidents.

Isvy-Joubert A, Ingen-Housz-Oro S, Vincent R, Haddad C, Valeyrie-Allanore L, Chosidow O, Race JM, Wolkenstein P.

Dermatology. 2014;228(4):338-43. doi: 10.1159/000358295. Epub 2014 Mar 19.

PMID:
24662107
[PubMed - in process]
2.

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes.

Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B; LEAD-3 (Mono) Study Group.

Diabetes Obes Metab. 2011 Apr;13(4):348-56. doi: 10.1111/j.1463-1326.2010.01356.x.

PMID:
21205128
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes.

Bode BW, Testa MA, Magwire M, Hale PM, Hammer M, Blonde L, Garber A; LEAD-3 Study Group.

Diabetes Obes Metab. 2010 Jul;12(7):604-12. doi: 10.1111/j.1463-1326.2010.01196.x.

PMID:
20590735
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA; ACCOMPLISH Trial investigators.

Lancet. 2010 Apr 3;375(9721):1173-81. doi: 10.1016/S0140-6736(09)62100-0. Epub 2010 Feb 18.

PMID:
20170948
[PubMed - indexed for MEDLINE]
5.

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.

Raskin P, Lewin A, Reinhardt R, Lyness W; Repaglinide/Metformin Fixed-Dose Combination Study Group.

Diabetes Obes Metab. 2009 Oct;11(10):947-52. doi: 10.1111/j.1463-1326.2009.01069.x. Epub 2009 Jun 16.

PMID:
19531054
[PubMed - indexed for MEDLINE]
6.

Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet.

Raskin P, Lewin A, Reinhardt R, Lyness W; Repaglinide/Metformin Fixed-Dose Combination Study Group.

Diabetes Obes Metab. 2009 Sep;11(9):865-73. doi: 10.1111/j.1463-1326.2009.01062.x. Epub 2009 May 19.

PMID:
19476470
[PubMed - indexed for MEDLINE]
7.

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators.

N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.

PMID:
19052124
[PubMed - indexed for MEDLINE]
Free Article
8.

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B; LEAD-3 (Mono) Study Group.

Lancet. 2009 Feb 7;373(9662):473-81. doi: 10.1016/S0140-6736(08)61246-5. Epub 2008 Sep 24.

PMID:
18819705
[PubMed - indexed for MEDLINE]
9.

Inhibition of IL-1beta transcription by peptides derived from the hCMV IE2 transactivator.

Listman JA, Race JE, Walker-Kopp N, Unlu S, Auron PE.

Mol Immunol. 2008 May;45(9):2667-77. doi: 10.1016/j.molimm.2007.12.024. Epub 2008 Mar 4.

PMID:
18308397
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Chorion type, birthweight discordance and tooth-size variability in Australian monozygotic twins.

Race JP, Townsend GC, Hughes TE.

Twin Res Hum Genet. 2006 Apr;9(2):285-91.

PMID:
16611500
[PubMed - indexed for MEDLINE]
11.

Conserved ETS domain arginines mediate DNA binding, nuclear localization, and a novel mode of bZIP interaction.

Listman JA, Wara-aswapati N, Race JE, Blystone LW, Walker-Kopp N, Yang Z, Auron PE.

J Biol Chem. 2005 Dec 16;280(50):41421-8. Epub 2005 Oct 13.

PMID:
16223730
[PubMed - indexed for MEDLINE]
Free Article
12.

Alcohol attentional bias as a predictor of alcohol abusers' treatment outcome.

Cox WM, Hogan LM, Kristian MR, Race JH.

Drug Alcohol Depend. 2002 Dec 1;68(3):237-43.

PMID:
12393218
[PubMed - indexed for MEDLINE]
13.

Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin-associated lactic acidosis'.

Lalau JD, Race JM.

Diabetes Obes Metab. 2001 Jun;3(3):195-201. Review.

PMID:
11412284
[PubMed - indexed for MEDLINE]
14.

Metformin retention independent of renal failure in intestinal occlusion.

Lalau JD, Race JM, Andreelli F, Lacroix C, Canarelli JP.

Diabetes Metab. 2001 Feb;27(1):24-8.

PMID:
11240442
[PubMed - indexed for MEDLINE]
Free Article
15.

Metformin and lactic acidosis in diabetic humans.

Lalau JD, Race JM.

Diabetes Obes Metab. 2000 Jun;2(3):131-7. Review. No abstract available.

PMID:
11220548
[PubMed - indexed for MEDLINE]
16.

Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter.

Race JE, Makhlouf FN, Logue PJ, Wilson FH, Dunham PB, Holtzman EJ.

Am J Physiol. 1999 Dec;277(6 Pt 1):C1210-9.

PMID:
10600773
[PubMed - indexed for MEDLINE]
Free Article
17.

Lactic acidosis in metformin therapy.

Lalau JD, Race JM.

Drugs. 1999;58 Suppl 1:55-60; discussion 75-82.

PMID:
10576527
[PubMed - indexed for MEDLINE]
18.

Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations.

Lalau JD, Race JM.

Drug Saf. 1999 Apr;20(4):377-84.

PMID:
10230584
[PubMed - indexed for MEDLINE]
19.

Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3).

Race JE, Grassl SM, Williams WJ, Holtzman EJ.

Biochem Biophys Res Commun. 1999 Feb 16;255(2):508-14.

PMID:
10049739
[PubMed - indexed for MEDLINE]
20.

Molecular characterization of two novel transporters from human and mouse kidney and from LLC-PK1 cells reveals a novel conserved family that is homologous to bacterial and Aspergillus nucleobase transporters.

Faaland CA, Race JE, Ricken G, Warner FJ, Williams WJ, Holtzman EJ.

Biochim Biophys Acta. 1998 Nov 8;1442(2-3):353-60.

PMID:
9804989
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk